Explore All Access
Check if your research matches the topics covered in Pharmacogenomics Journal?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Pharmacogenomics Journal : Impact Factor & More
eISSN: 1473-1150pISSN: 1470-269X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Pharmacogenomics Journal Key Metrics
CiteScore 
6.5
H-Index
93
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1
Time to Accept
7
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months14%
4 to 6 months28%
7 to 9 months28%
Above 9 months31%
Did you find this useful?
Topics Covered on Pharmacogenomics Journal
Genetic testing
Genotype
Overall survival
Nephrotic syndrome
Chronic pain
Clinical significance
Colorectal cancer
Rheumatoid arthritis
Pharmacogenomics
CYP2C19
Essential hypertension
Allele
Myocardial infarction
Docetaxel
Glioblastoma
Treatment failure
Major depressive disorder
Odds ratio
Ovarian cancer
Multivariate analysis
Pharmacogenomics Journal Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacogenomics Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmacogenomics Journal
Genetic association analysis and frequency of NUDT15*3 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort.
- 23 Nov 2024
- The pharmacogenomics journal
Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey study.
- 22 Nov 2024
- The pharmacogenomics journal
Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective study
- 22 Nov 2024
- The Pharmacogenomics Journal
Implementation of pharmacogenetic testing in pediatric oncology: barriers and facilitators assessment at eight Canadian academic health centres.
- 19 Nov 2024
- The pharmacogenomics journal
Correction to: A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform.
- 18 Nov 2024
- The pharmacogenomics journal
TMEM158, as plasma cfRNA marker, promotes proliferation and doxorubicin resistance in ovarian cancer.
- 15 Nov 2024
- The pharmacogenomics journal
Genetic association analysis and frequency of NUDT15*3 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort.
- 23 Nov 2024
- The pharmacogenomics journal
Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey study.
- 22 Nov 2024
- The pharmacogenomics journal
Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective study
- 22 Nov 2024
- The Pharmacogenomics Journal
Implementation of pharmacogenetic testing in pediatric oncology: barriers and facilitators assessment at eight Canadian academic health centres.
- 19 Nov 2024
- The pharmacogenomics journal
Correction to: A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform.
- 18 Nov 2024
- The pharmacogenomics journal
TMEM158, as plasma cfRNA marker, promotes proliferation and doxorubicin resistance in ovarian cancer.
- 15 Nov 2024
- The pharmacogenomics journal
Compare Similar Journals with Pharmacogenomics Journal
Select Journals to Compare with Pharmacogenomics Journal
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Scientific Reports
Publisher: NATURE PORTFOLIO
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Medicine
Publisher: Elsevier
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Journal of Clinical Medicine
Publisher: MDPI
International Journal of Molecular Sciences
Publisher: MDPI
Cancers
Publisher: MDPI
Oncotarget
Publisher: Impact Journals
0 Journals Selected to compare with
Pharmacogenomics Journal
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Pharmacogenomics Journal
How long has Pharmacogenomics Journal been actively publishing? 
Pharmacogenomics Journal has been in operation since 2001 till date.
What is the publishing frequency of Pharmacogenomics Journal?
Pharmacogenomics Journal published with a Bi-monthly frequency.
How many articles did Pharmacogenomics Journal publish last year?
In 2024, Pharmacogenomics Journal publsihed 39 articles.
What is the eISSN & pISSN for Pharmacogenomics Journal?
For Pharmacogenomics Journal, eISSN is 1473-1150 and pISSN is 1470-269X.
What is Citescore for Pharmacogenomics Journal?
Citescore for Pharmacogenomics Journal is 6.5.
What is the H Index for Pharmacogenomics Journal ?
H Index for Pharmacogenomics Journal is 93.
What is SNIP score for Pharmacogenomics Journal?
SNIP score for Pharmacogenomics Journal is 1.
What is the SJR for Pharmacogenomics Journal?
SJR for Pharmacogenomics Journal is Q2.
Who is the publisher of Pharmacogenomics Journal?
SPRINGERNATURE is the publisher of Pharmacogenomics Journal.
